T1	intervention 28 38	Carvedilol
T2	No-of-participants 426 428	91
T3	intervention-participants 565 567	46
T4	control 572 579	placebo
T5	control-participants 585 587	45
T6	outcome-Measure 678 771	changes in the mean left ventricular ejection fraction, left ventricular end diastolic volume
T7	outcome-Measure 777 813	left ventricular end systolic volume
T8	outcome-Measure 848 962	percentage change in the left atrial (LA) diameter and other variables of left ventricular (LV) diastolic function
T9	outcome-Measure 1355 1407	tissue Doppler mitral annular systolic (s') velocity
T10	outcome-Measure 1464 1474	E/e' ratio
T11	outcome-Measure 1521 1537	troponin I level
T12	outcome 1621 1655	left ventricular ejection fraction
T13	outcome 1814 1866	left ventricular end systolic volume and LA diameter
T14	outcome 1980 2031	pulmonary venous peak atrial reversal flow velocity
T15	outcome 2122 2190	mitral annuli early diastolic (e') and peak systolic (s') velocities
T16	outcome 2225 2271	E (the peak early diastolic velocity)/e' ratio
T17	outcome 2435 2444	TnI level
